4//SEC Filing
Sarepta Therapeutics, Inc. 4
Accession 0001209191-16-142359
$SRPTCIK 0000873303operating
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 9:31 PM ET
Size
14.3 KB
Accession
0001209191-16-142359
Insider Transaction Report
Form 4
Aphale Jayant
SVP Technical Operations
Transactions
- Exercise/Conversion
Incentive Stock Options (right to buy)
2016-09-19$4.62/sh−25,000$115,500→ 61,580 totalExercise: $4.62From: 2012-12-22Exp: 2021-12-22→ Common Stock (25,000 underlying) - Exercise/Conversion
Non-Qualified Stock Options (right to buy)
2016-09-19$4.62/sh−10,000$46,200→ 3,420 totalExercise: $4.62From: 2012-12-22Exp: 2021-12-22→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2016-09-19$4.62/sh+10,000$46,200→ 21,490 total - Sale
Common Stock
2016-09-19$50.00/sh−10,000$500,000→ 11,490 total - Exercise/Conversion
Common Stock
2016-09-19$4.62/sh+25,000$115,500→ 36,490 total - Sale
Common Stock
2016-09-19$50.00/sh−25,000$1,250,000→ 11,490 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on December 11, 2015, accordingly, the reporting person had no discretion with regards to the timing of the transaction.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000873303
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 9:31 PM ET
- Size
- 14.3 KB